Quell Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Quell Therapeutics's estimated annual revenue is currently $26.8M per year.
- Quell Therapeutics's estimated revenue per employee is $155,000
Employee Data
- Quell Therapeutics has 173 Employees.
- Quell Therapeutics grew their employee count by 5% last year.
Quell Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | Executive Management Assistant - Chief Manufacturing Officer (CMO) / Deputy EA to CEO. | Reveal Email/Phone |
2 | Chief Manufacturing Officer | Reveal Email/Phone |
3 | CEO | Reveal Email/Phone |
4 | Co-founder & VP Biology | Reveal Email/Phone |
5 | VP, Human Resources | Reveal Email/Phone |
6 | VP clinical operations | Reveal Email/Phone |
7 | Director / Non-Clinical Group Leader | Reveal Email/Phone |
8 | Director/Team Lead Discovery and New Technologies | Reveal Email/Phone |
9 | Chief Scientific Officer | Reveal Email/Phone |
10 | Senior Director, Portfolio Strategy and Alliance Management | Reveal Email/Phone |
Quell Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.5M | 29 | -12% | N/A | N/A |
#2 | $15.7M | 101 | 5% | N/A | N/A |
#3 | $87.9M | 405 | 25% | $292M | N/A |
#4 | $2.6M | 470 | 16% | $631.7M | N/A |
#5 | $14.9M | 96 | -8% | $81M | N/A |
#6 | $44.8M | 231 | 0% | $132.9M | N/A |
#7 | $7.6M | 49 | -37% | N/A | N/A |
#8 | $17.4M | 112 | 12% | N/A | N/A |
#9 | $334.6M | 1349 | 11% | £994.6M | N/A |
#10 | $830.2M | 5356 | 8% | N/A | N/A |
What Is Quell Therapeutics?
An exciting new cell therapy immunology biotech committed to transforming patient's lives in solid organ transplantation and auto-immune conditions. Our company is growing and we are exciting about the future! Our vision is to become a world leader in new cell therapy and the people are at the heart of what we do. We treat our people with respect, working collaboratively across the business, taking ownership and accountability for the outcomes and results we delivery. Most of all we work with integrity to innovate and bring the best version of ourselves to the job every day.
keywords:N/AN/A
Total Funding
173
Number of Employees
$26.8M
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Quell Therapeutics News
Quell Therapeutics Ltd., of London, entered a collaboration for the co-development of an induced pluripotent stem cell (iPSC)-derived Treg...
Quell Therapeutics and Cellistic aim to develop next-gen platform for creation of off-the-shelf Treg cell therapies targeting a wide range...
Quell Therapeutics and Cellistic enter a strategic collaboration to develop an iPSC-derived allogeneic T-regulatory (Treg) cell therapy...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $34.3M | 173 | 10% | N/A |
#2 | $47.6M | 173 | -2% | N/A |
#3 | $41.9M | 173 | 8% | N/A |
#4 | $51.4M | 173 | -2% | N/A |
#5 | $35M | 173 | -1% | N/A |